Pro PG receives S19A approval for Gemfibrozil Tablets USP 600mg (Cipla USA)
Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered Gemfibrozil products on a temporary basis:
Gemfibrozil Tablets USP 600mg (Cipla USA)
This products are NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st July 2022.
Please contact us for more information.
